Quality of Perioperative Invasive Ventilation in PICU

November 23, 2020 updated by: University of Oulu

Electrical Impedance Tomography (EIT) in Assessing the Quality of Perioperative Invasive Ventilation in PICU

This is purely observational study in which quality of invasive ventilation is observed with electrical impedance tomography (EIT) during perioperative intensive care. EIT parameters will be used to assess if protective ventilation strategies are successfully followed during routine care.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

20 neonates and infants undergoing elective surgery and requiring postoperative treatment and follow up in PICU or in pediatric anestesiology clinic, will be included in this prospective observational study. Swisstom BB2-monitor and NeoSensorBelts will be used to monitor their ventilatory care from arrival to the operation room (prior intubation) to postoperative intensive care (until 2 hours after extubation). EIT parameters assessing lung aeration and ventilation distribution will be used to assess the quality of invasive ventilation.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oulu, Finland
        • Oulu University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 hours to 1 year (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Neonates and infants undergoing elective/semi-elective surgery

Description

Inclusion Criteria:

  • Written informed consent from a parent of legal guardian
  • Infant undergoing elective or semi-elective surgery
  • Postoperative admission to PICU expected
  • Spontaneous breathing prior to study inclusion

Exclusion Criteria:

  • Need for respiratory support prior to surgery
  • Thoracic surgery
  • Body weight < 1500g or > 10 kg

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Silent spacies
Time Frame: 24 hours
Amount of silent spaces observed in different phases of treatment in comparison to baseline
24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ventilation distribution
Time Frame: 24 hours
Changes from baseline in ventilation distribution will be assessed in different phases of treatment
24 hours
Effect of interventions on ventilatory parameters
Time Frame: 24 hours
Relationship between intubation/invasive ventilation/extubation/spontaneous breathing and EIT findings
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Merja Kallio, MD, PhD, Oulu University Hospital and PEDEGO research group, University of Oulu
  • Principal Investigator: Marika Rahtu, Oulu University Hospital and PEDEGO research group, University of Oulu

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 3, 2018

Primary Completion (Actual)

October 6, 2020

Study Completion (Actual)

October 6, 2020

Study Registration Dates

First Submitted

February 27, 2018

First Submitted That Met QC Criteria

February 27, 2018

First Posted (Actual)

March 6, 2018

Study Record Updates

Last Update Posted (Actual)

November 24, 2020

Last Update Submitted That Met QC Criteria

November 23, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • EETTMK:36/2017

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Elective Surgery

Clinical Trials on Swisstom BB2 EIT device

3
Subscribe